Precision for Medicine

Put your next breakthrough on the map.

Explore the many routes your research can take and how Precision for Medicine can confidently guide you through each one. Whether your path is clearly defined or you’re venturing into uncharted scientific territory, integrated labs, global CRO capabilities, and deep oncology expertise ensure you never lose direction on the way to breakthrough results.

From feasibility and biospecimen sourcing to multi‑omic exploration, proprietary technologies, and either full-service for FSP model support, Precision brings clarity, speed, and scientific rigor to every step of your journey.

With expertise spanning immunotherapy, ADCs, and cell and gene therapies, plus NGS‑characterized and pathologist‑annotated biospecimens, Precision delivers the insights and execution to move you seamlessly from discovery to development without detours.

Visit Booth #2111, share your research path, and grab a “Science Harder” T‑shirt.

Harpreet Singh, MD

Chief Medical Officer

(SizeLimitingPyList: [linkedin])
Matt Grow

Chief Commercial Officer

(SizeLimitingPyList: [linkedin])
Deb Phippard

Chief Scientific Officer

(SizeLimitingPyList: [linkedin])
Danielle Ashley

Senior Vice President, Strategic Business Development

(SizeLimitingPyList: [linkedin])
Angelina Bisconte

Vice President, Translational Biology

(SizeLimitingPyList: [linkedin])

Jing Ping Yeo, PhD, MBA

Vice President, Clinical Operations & Head, Asia Pacific

(SizeLimitingPyList: [linkedin])
Zhenfei Yin, MM

China Country Manager & Senior Director, Project Management

(SizeLimitingPyList: [linkedin])
Maggie Curnutte

Senior Director, IVD Regulatory Consulting

(SizeLimitingPyList: [linkedin])
Natacha Grand, PhD

Senior Director, Operational Strategy

(SizeLimitingPyList: [linkedin])

Regulatory Science and Policy

Date: Monday, April 20 at 09:00 AM - 12:00 PM
Abstract Number: 1400 (Poster Section 2)
Presenter: Margaret Curnutte, Senior Director, IVD Regulatory Consulting
Adoptive Cell Therapy 2

Date: Tuesday, April 21 at 09:00 AM - 12:00 PM
Abstract Number: 5185 (Poster Section 40)
Presenter: Angelina Bisconte, Vice President, Translational Biology
High-Dimensional Immune Profiling and Preclinical Modeling for Cancer Immunotherapy

Date: Wednesday, April 22 at 9:00 AM - 12:00 PM
Abstract Number: 6954 (Poster Section 7)
Presenter: Angelina Bisconte, Vice President, Translational Biology

Precision is custom built to address today’s biomarker needs

Interrogating biological samples drives insight into preclinical and clinical development. Today, the challenge is not only how to select and implement assays with quality and at scale but also how to manage the vast data sets that are generated to deliver insights and decisions. Connect with our translational experts to overcome these challenges.

Discover resources

Brochure

Why Multi-Omic Insights Demand a Multi-Omic Strategy

Curated Resources

Expert guidance to streamline your path from bench to bedside, informed by real-world research.

Explore resources

Brochure
Guiding the Way for Novel Therapeutics in Complex Indications
Download Brochure
Whitepaper
Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials
Download Whitepaper
Brochure
Translational and Biomarker Sciences: Enabling Breakthroughs
Download Brochure
Info Sheet
Biospecimens That Come With Answers
Download Info Sheet

AACR 2026

Booth #2111

Mapping Your Journey from Insight to Outcome

Put your next breakthrough on the map.

Meet Precision Executive Leaders and Experts

Precision Thought Leadership at AACR 2026

Precision is custom built to address today’s biomarker needs

Meet our team!

Curated Resources

Guiding the Way for Novel Therapeutics in Complex Indications

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

Translational and Biomarker Sciences: Enabling Breakthroughs

Biospecimens That Come With Answers